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A 
33-y-old man presented to his primary care 
practitioner with a rash beginning around the left 
ear and spreading into the periorbital region. He was 
known to have eczema (atopic dermatitis), and the diagnosis 
of secondary bacterial infection and periorbital cellulitis was 
made. 
Because of a history of penicillin allergy, the patient was 
started on erythromycin. This treatment had no effect, and 
the rash extended. On day 4, he presented to the hospital 
accident and emergency department. He was systemically 
unwell, complaining of drenching sweats and rigors. On 
examination he was alert, he was pyrexial at 39.2 °C, his pulse 
was 100 bpm, and his blood pressure was 128/70 mm Hg. 
There was a widespread erythematous rash covering his face, 
chest, and arms, which was described as wet with a yellowish 
exudate. The rash extended around both eyes, which could 
not be opened (Figure 1). 
The patient had a history of atopic eczema (since 
childhood), rhinitis, and asthma. He was taking inhaled 
corticosteroids for asthma and had last received a course 
of systemic steroids one year previously. There were no risk 
factors for HIV infection.
Which Investigations Were Now Indicated?
In many patients with a rash, the morphology of the rash 
will lead to a provisional clinical diagnosis, and it may be 
sufﬁ  ciently characteristic for no conﬁ  rmatory tests to be 
needed. An example is the typical rash of shingles. There 
are two broad reasons for doing investigations in a patient 
presenting with fever and a rash. Firstly, speciﬁ  c tests—such 
as blood tests, cultures, or a skin biopsy—may be required to 
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DESCRIPTION of CASE
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Figure 1. Appearance of Part of the Face and Shoulder at Presentation to 
Hospital
There are multiple shallow ulcers with copious creamy exudates 
and some crusting. A few intact vesicles are also visible. The right 
eye was closed by exudates.PLoS Medicine  |  www.plosmedicine.org 122
help establish the diagnosis. In this 33-y-old patient, the rash 
was thought likely to be a skin infection, and so the speciﬁ  c 
tests that were indicated included viral and bacterial cultures. 
A skin biopsy would have been considered if the diagnosis 
remained unclear and the patient was not responding to 
empirical antimicrobial therapy. Secondly, investigations 
are used to evaluate how ill the patient is and whether there 
is any organ involvement beyond the skin. In this case, we 
were most concerned about severe sepsis with a risk of organ 
failure.
Investigations showed the following: haemoglobin, 128 
g/L (normal range, 135–170 g/L); white blood cell count, 
9.9 × 109/l (normal range, 3.5–12.5 × 109/l); and differential 
white blood cell count, 90% neutrophils with a left shift. 
The patient was hyponatraemic (his sodium was 126 mmol/l 
[normal range, 135–145]), but renal and liver function tests 
were normal. C-reactive protein was 140 mg/l (normal level, 
<10 mg/l). Chest X ray was normal. Blood cultures and skin 
swabs were taken along with samples for viral culture and 
polymerase chain reaction (PCR).
What Was the Provisional Diagnosis?
A provisional diagnosis of bacterially infected eczema was 
made, and, in view of his history of penicillin allergy, the 
patient was started on intravenous vancomycin. He was 
admitted and referred for dermatology, infectious diseases, 
and ophthalmology reviews.
On closer inspection of the rash, it was apparent that there 
were multiple small vesicles 1–2 mm in diameter and shallow 
ulcers over the face and periorbital region (Figure 1). There 
was extensive exudate on the skin of the eyelids of both eyes. 
It was not possible to open the right eye, but in the left eye, 
the cornea was clear and there was no evidence of disease.
How Did This Information Affect the Likely Diagnosis?
In view of the characteristic picture and underlying eczema, 
the diagnosis was revised to one of severe eczema herpeticum. 
The patient denied any previous history of oral cold sores 
or genital ulceration. However, the severe degree of skin 
inﬂ  ammation, high fever, raised C-reactive protein, and left-
shifted neutrophils suggested co-existent bacterial sepsis. 
What Was the Management Approach?
High-dose intravenous aciclovir (10 mg/kg every 8 h) was 
started. Aciclovir inhibits thymidine kinase, which is an 
essential enzyme for several herpes viruses. Aciclovir has 
excellent activity against herpes simplex virus (HSV), and, 
although less potent, it is also effective against varicella zoster 
virus [1]. It has only weak activity against cytomegalovirus and 
Epstein-Barr virus [1].
This man had severe skin involvement with a high 
likelihood of complicating bacterial sepsis, which is most 
commonly due to Staphylococcus aureus [2]. Erythromycin 
had originally been prescribed, but increasing erythromycin 
resistance makes this a poor choice in many parts of 
the world. In view of his penicillin allergy, vancomycin 
was continued and ciproﬂ  oxacin added to broaden 
the antibacterial spectrum. Vancomycin disrupts the 
peptidoglycan bonding of the gram-positive bacterial cell 
wall and has no activity against gram-negative bacteria. 
Ciproﬂ  oxacin is a DNA gyrase inhibitor with excellent activity 
against many gram-negative bacteria, but it is less effective for 
gram-positive organisms. Aciclovir and chlorampenicol were 
administered topically to both eyes, and this treatment was 
successful in preventing corneal involvement.
Two separate sets of blood cultures subsequently grew S. 
aureus, which was resistant to penicillin, erythromycin, and 
clindamycin but sensitive to all other agents. Skin and eye 
swabs also grew S. aureus. HSV DNA was identiﬁ  ed by PCR 
on ﬂ  uid taken from the face. Viral cultures were positive for 
HSV-1. Serology taken on admission was positive for HSV-1 
IgG. 
Progress
The patient rapidly defervesced, and the vesicles 
desquamated on day 6 (Figure 2). He was discharged after a 
total hospital stay of 16 d. He returned to the clinic 2 wk later, 
at which point the skin was healing well (Figure 3). 
What Complications Should Be Looked Out for?
In the acute stage of his presentation, our two main concerns 
for this patient were the extent of involvement of the eyes 
beneath the eyelids and the positive blood cultures for 
S. aureus. As mentioned above, the eyes were proactively 
managed to avoid corneal involvement. The S. aureus 
bacteraemia could have progressed to severe sepsis or led 
to metastatic spread of infection. Echocardiogram was 
normal with no evidence of endocarditis, and intravenous 
vancomycin was continued for a period of 14 d to minimize 
the risk of metastatic spread. Close attention to infection 
control procedures is essential to prevent hospital-acquired 
infection of the damaged skin or intravenous line sites. 
DISCUSSION
Eczema Herpeticum
Kaposi’s varicelliform eruption describes the widespread 
dermal infection caused predominantly by HSV-1 in patients 
with a variety of skin conditions [3]. It is most commonly 
seen in patients with pre-existing atopic eczema, in which 
case it is known as eczema herpeticum. Disease severity 
varies from mild, transient disease to a fulminating fatal 
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Figure 2. Appearance on Day 5
Most of the exudate has cleared, and all vesicles have 
desquamated. The eyes are now open, and the skin is beginning 
to heal.PLoS Medicine  |  www.plosmedicine.org 123
disorder involving the visceral organs. Death is very rare in 
immunocompetent adults; fulminant disease is more likely 
in severely immunocompromised individuals. The incidence 
of eczema herpeticum is increasing, especially in the context 
of sexually transmitted disease [4]. Most cases are caused by 
reactivation of HSV rather than primary infection [3]. Our 
patient had no clinical history of infection with herpes, but 
HSV-1 was conﬁ  rmed by both PCR and culture. The positive 
HSV-1 IgG titre suggests that this was reactivation of latent 
infection. 
Prompt use of antiviral therapy is highly effective in 
controlling HSV replication. Aciclovir is the antiviral agent 
of choice and is usually given for 7 d. Patients with moderate 
to severe disease require admission for intravenous aciclovir. 
Oral aciclovir is effective for mild cases, which can be 
managed on an outpatient basis [5]. Bacterial superinfection 
is common in severe eczema herpeticum [2], and antibiotic 
therapy is required in severe cases. Valaciclovir (a pro-drug of 
aciclovir) and famciclovir are available in oral preparations 
and can be considered as alternative antivirals where oral 
therapy is an option [1]. In addition to the treatment 
of systemic infection, skin and eye lesions require very 
careful management, and specialised dermatology [6] and 
ophthalmology input are essential [7].
A proportion of patients may experience recurrent attacks 
of eczema herpeticum [4]. Recurrences are generally 
diagnosed and treated rapidly, as both the patients and 
their physicians have become familiar with the disease. 
With frequent recurrences, prophylactic aciclovir may 
be considered, although there are insufﬁ  cient data to 
recommend its use routinely. Good control of eczema is also 
important to reduce the risk of recurrence [3].
Which Patients with Atopic Eczema Are at Risk of 
Eczema Herpeticum?
A recent retrospective analysis of 100 cases of eczema 
herpeticum in patients with atopic ezcema highlighted some 
predisposing factors. The analysis found that patients with 
eczema herpeticum had developed atopic eczema earlier and 
had higher total serum IgE levels than control patients with 
atopic eczema alone [3]. In addition, 75% of the patients 
with eczema herpeticum had not received corticosteroid 
treatment in the 4 wk preceding onset of eczema herpeticum. 
The authors of the analysis concluded that most cases of 
eczema herpeticum occurred in patients with untreated 
atopic eczema. Thus, effective control of eczema is important 
to prevent eczema herpeticum. Such control is particularly 
important in our patient to prevent further attacks of eczema 
herpeticum. 
Making the Correct Diagnosis
The rapidly progressive, widespread, crusted papules, 
vesicles, and erosions in a patient with atopic eczema are 
characteristic, and an experienced physician who has 
seen eczema herpeticum before will make a rapid clinical 
diagnosis. However, some patients present with atypical or 
purely crusted lesions and no obvious vesicles, making a 
clinical diagnosis more difﬁ  cult. Thus, a high index of clinical 
suspicion is required, and both viral and bacterial cultures are 
essential when a patient with atopic eczema presents with a 
spreading vesicular or crusting rash [4]. Rapid conﬁ  rmation 
of cutaneous HSV can be achieved with immunoﬂ  uorescent 
techniques or PCR, but these are not yet available in many 
centres [8].
Smallpox Vaccination
A similar and potentially fatal disease may follow smallpox 
vaccination [9,10]. Until recently, this was only of academic 
interest, given the global eradication of smallpox. Recent 
events have raised the spectre of smallpox returning, however, 
and some countries have begun stockpiling vaccine and 
inoculating key health-care workers. Smallpox vaccination 
involves the intradermal inoculation of live attenuated variola 
virus by scariﬁ  cation, and the site may shed live virus for 2–3 
wk until the lesion heals. In a person with eczema, the variola 
virus can cause widespread eczema vaccinatum. As the variola 
virus is shed into the environment from the vaccine site, it 
can also spread to close contacts with eczema, which can lead 
to secondary cases of eczema vaccinatum. This risk is greatly 
diminished with the use of an appropriate occlusive dressing 
to the vaccination site. It is reassuring that, so far, no cases 
of eczema vaccinatum have been reported in the United 
States following the recent smallpox vaccination programme, 
but this disease may well return if there is need for more 
extensive smallpox vaccination.  
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Figure 3. Appearance on Day 28
All ulcers have resolved, and healing is almost complete.
Key Learning Points
▪ Eczema herpeticum is an uncommon but potentially fatal 
disorder that can present to primary care practitioners or to the 
emergency department. 
▪ Diagnostic delay is common and may increase morbidity. 
▪ First-line therapy is with acyclovir; intravenous high-dose 
therapy is required in severe cases.
▪ Patients should be referred to a dermatologist for specialist 
care and follow-up to optimise eczema management, so that 
recurrence is less likely. 
▪ Intensive nursing care is indicated to minimise scarring and 
promote rapid healing.
▪ If the periorbital region is involved, refer urgently to an 
ophthalmologist.PLoS Medicine  |  www.plosmedicine.org 124
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